Insulin Action Research Articles

Analysis of Genetic Spectrum in Polycystic Ovary Syndrome- A Review

Polycystic ovary syndrome (PCOS) is increase in an alarming rate since 1935. According to WHO the prevalence rate of PCOS is 3.4% worldwide. Hyperandrogenism, chronic anovulation, small cysts and increase in size of the ovary are the most common diagnostic feature for PCOS. Beside the environmental factors PCOS is highly associated with genetic back up of an individual. So, Different genetic pathways like steroid hormone synthesis , ovarian and adrenal steroidogenesis, gonadotropin action, insulin action and secretion, energy homeostasis , chronic inflammation pathways plays most important role in PCOS progression. Furthermore several report suggested that, some other genes like plasminogen activator inhibitor-1 (PAI-1), HSD3B2 , 17α-hydroxysteroid dehydrogenases, dopamine receptor, IGF107, aldosterone synthetase , paraoxonase, glycogen synthetase, resistin, apoprotein E are also involved in PCOS progression. From different case report it is established that epilepsy and diabetes condition are the two main regulators for PCOS progression. Whereas, epigenetic mechanism is also involved in the pathogenesis of PCOS. Some of the therapeutics is also available for treatment of PCOS but not ensure proper cure. Long-term treatment for PCOS, increases the risk of developing metabolic and cardiovascular abnormalities. So the main aim of this review is to reveal all aspects of genetics mechanism related to PCOS for better understanding of the disease. As well as established a profile of regulatory marker gene for early diagnosis and to develop a better treatment protocol.

Changes in Cells Associated with Insulin Resistance.

Insulin is a polypeptide hormone synthesized and secreted by pancreatic β-cells. It plays an important role as a metabolic hormone. Insulin influences the metabolism of glucose, regulating plasma glucose levels and stimulating glucose storage in organs such as the liver, muscles and adipose tissue. It is involved in fat metabolism, increasing the storage of triglycerides and decreasing lipolysis. Ketone body metabolism also depends on insulin action, as insulin reduces ketone body concentrations and influences protein metabolism. It increases nitrogen retention, facilitates the transport of amino acids into cells and increases the synthesis of proteins. Insulin also inhibits protein breakdown and is involved in cellular growth and proliferation. On the other hand, defects in the intracellular signaling pathways of insulin may cause several disturbances in human metabolism, resulting in several chronic diseases. Insulin resistance, also known as impaired insulin sensitivity, is due to the decreased reaction of insulin signaling for glucose levels, seen when glucose use in response to an adequate concentration of insulin is impaired. Insulin resistance may cause, for example, increased plasma insulin levels. That state, called hyperinsulinemia, impairs metabolic processes and is observed in patients with type 2 diabetes mellitus and obesity. Hyperinsulinemia may increase the risk of initiation, progression and metastasis of several cancers and may cause poor cancer outcomes. Insulin resistance is a health problem worldwide; therefore, mechanisms of insulin resistance, causes and types of insulin resistance and strategies against insulin resistance are described in this review. Attention is also paid to factors that are associated with the development of insulin resistance, the main and characteristic symptoms of particular syndromes, plus other aspects of severe insulin resistance. This review mainly focuses on the description and analysis of changes in cells due to insulin resistance.

Emerging and multifaceted potential contributions of polyphenols in the management of type 2 diabetes mellitus.

Type 2 diabetes mellitus (T2DM) is recognized as a serious public health concern with a considerable impact on human life, long-term health expenditures, and substantial health losses. In this context, the use of dietary polyphenols to prevent and manage T2DM is widely documented. These dietary compounds exert their beneficial effects through several actions, including the protection of pancreatic islet β-cell, the antioxidant capacities of these molecules, their effects on insulin secretion and actions, the regulation of intestinal microbiota, and their contribution to ameliorate diabetic complications, particularly those of vascular origin. In the present review, we intend to highlight these multifaceted actions and the molecular mechanisms by which these plant-derived secondary metabolites exert their beneficial effects on type 2 diabetes patients.

Insulin at the intersection of thermoregulation and glucose homeostasis

Mammals are protected from changes in environmental temperature by altering energetic processes that modify heat production. Insulin is the dominant stimulus of glucose uptake and metabolism, which are fundamental for thermogenic processes. The purpose of this work was to determine the interaction of ambient temperature induced changes in energy expenditure (EE) on the insulin sensitivity of glucose fluxes. Short-term and adaptive responses to thermoneutral temperature (TN, ∼28 °C) and room (laboratory) temperature (RT, ∼22 °C) were studied in mice. This range of temperature does not cause detectable changes in circulating catecholamines or shivering and postabsorptive glucose homeostasis is maintained. We tested the hypothesis that a decrease in EE that occurs with TN causes insulin resistance and that this reduction in insulin action and EE is reversed upon short term (<12h) transition to RT. Insulin-stimulated glucose disposal (Rd) and tissue-specific glucose metabolic index were assessed combining isotopic tracers with hyperinsulinemic-euglycemic clamps. EE and insulin-stimulated Rd are both decreased (∼50%) in TN-adapted vs RT-adapted mice. When RT-adapted mice are switched to TN, EE rapidly decreases and Rd is reduced by ∼50%. TN-adapted mice switched to RT exhibit a rapid increase in EE, but whole-body insulin-stimulated Rd remains at the low rates of TN-adapted mice. In contrast, whole body glycolytic flux rose with EE. This higher EE occurs without increasing glucose uptake from the blood, but rather by diverting glucose from glucose storage to glycolysis. In addition to adaptations in insulin action, ‘insulin-independent’ glucose uptake in brown fat is exquisitely sensitive to thermoregulation. These results show that insulin action adjusts to non-stressful changes in ambient temperature to contribute to the support of body temperature homeostasis without compromising glucose homeostasis.

Penerapan Terapi Relaksasi Otot Progresif Masalah pada Keluarga dengan Diabetes Gangguan Kenyamanan

Diabetes is a group of metabolic diseases characterized by hyperglycemia due to abnormalities in insulin secretion, insulin action, or both. This case study uses a descriptive method with a nursing approach. This research was carried out from March 15 to March 21 2023 and continued from March 25 to March 31 2023. The research subjects were 2 people who were given nursing progressive muscle relaxation therapy for 6 consecutive days. This research was conducted in the work area of the Palembang Community Health Center. The research results after progressive muscle relaxation therapy showed that the client's comfort situation improved and showed significant differences in blood sugar levels on the first and sixth days after progressive muscle relaxation therapy. Client 1 was 242 mg/dL on day 1 and 200 mg/dL on day 6, while client 2 was 224 mg/dL on day 1 and dropped to 195 mg/dL on day 6. Sir. Conclusion: Progressive muscle relaxation can increase comfort and also reduce blood sugar in diabetes patients.

Osteoarticular complications in diabetes - literature review

Due to the increasing number of patients suffering from diabetes mellitus scientists raise awareness of different symptoms that patients might present.&#x0D; The disease results from a defect in insulin secretion or action. Chronic hyperglycemia in diabetes causes damage and dysfunction of organs, especially the eyes, kidneys, nerves, heart and blood vessels. Diabetes can occur at any age and always requires treatment. &#x0D; A common non-specific symptom of untreated DM may be osteoarticular complications.&#x0D; Typical symptoms of diabetes include polyuria, increased thirst, dehydration, weakness and drowsiness. Complications of the disease include eyes, kidneys, nerves, microangiopathies, diabetic foot syndrome, bones, joints, skin. In all patients, the most important thing is to control glycemia from the beginning of the disease

EFFECT OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL VALUE ON NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) IN PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW

Introduction &amp; Objectives : Type 2 Diabetes Mellitus (T2DM) is a metabolic disease in which the body is unable to control blood sugar levels and is characterized by hyperglycemia caused by lack of insulin action. One of the most common microvascular complications of DM that can cause blindness to sufferers is Diabetic Retinopathy (DR). One of the risk factors that can exacerbate the progression of T2DM is the level of Low-Density Lipoprotein (LDL). However, there are still differences of opinion in several studies if LDL has a significant role in the occurrence of DR. This study aimed to determine whether there is a relationship between the value of LDL cholesterol and the occurrence of Non-Proliferative Diabetic Retinopathy.&#x0D; Methods : Systematic review utilizing MeSH terminology and PICO methods were done for information extraction of online database, including PubMed, and Google Scholar by utilizing the following keyword “Low-Density Lipoprotein”, “Non-Proliferative Diabetic Retinopathy”, “Diabetes Melitus”. The extracted studies were then analyzed using the New-Castle Ottawa Scale (NOS).&#x0D; Results : In total, 2 eligible studies (103 subjects) were found. Dornan et al., stated that total cholesterol levels were higher in NPDR Patients (5.1 +/- 0.7 mmol/l, p ? 0,02) and Mursi et al., shows that in patients with uncontrolled LDL cholesterol, NPDR was found (53,7%, p &lt; 0,015). NOS was used to evaluate the quality of the studies and all studies showed to be in good quality.&#x0D; Conclusion : According to the results of this systematic review, there is a significant correlation between the degree of diabetic retinopathy and LDL cholesterol.

Detection of type-Ⅱ diabetes using graphene-based biosensors

Diabetes is a global pandemic that increases the risk of various health complications, including heart attacks, renal failure, blindness, stroke, and peripheral neuropathy. Type-2 diabetes (T2D) results from an imbalance in lipid and glucose metabolism due to hostility to insulin action and insufficient insulin production response. Valine amino acid has been identified as a potential biomarker for T2D, but there have been no rigorous studies on its interaction with branch chain amino acids. In this study, we investigated the potential of graphene/modified graphene as a valine biosensor using density functional theory to examine the electronic properties and adsorption behaviour of graphene, Si-doped graphene (SiG), and P-doped graphene (PG). The adsorption of valine over the substrates was physisorption in nature, and the adsorption energies were in the order of SiG > G > PG. Density of states (DOS) and partial DOS calculations confirmed the molecule’s adsorption over the monolayers and indicated variations in the electronic properties. We also performed recovery time calculations to examine the reusability of the nano-surfaces as potential biosensors. Ultrafast recovery times were predicted for all three systems, with SiG showing the best results. Our study suggests that SiG could be used as a biosensor for valine, providing a real-time and efficient diagnostic tool for T2D.

The genetic and dietary landscape of the muscle insulin signalling network.

Metabolic disease is caused by a combination of genetic and environmental factors, yet few studies have examined how these factors influence signal transduction, a key mediator of metabolism. Using mass spectrometry-based phosphoproteomics, we quantified 23,126 phosphosites in skeletal muscle of five genetically distinct mouse strains in two dietary environments, with and without acute in vivo insulin stimulation. Almost half of the insulin-regulated phosphoproteome was modified by genetic background on an ordinary diet, and high-fat high-sugar feeding affected insulin signalling in a strain-dependent manner. Our data revealed coregulated subnetworks within the insulin signalling pathway, expanding our understanding of the pathway's organisation. Furthermore, associating diverse signalling responses with insulin-stimulated glucose uptake uncovered regulators of muscle insulin responsiveness, including the regulatory phosphosite S469 on Pfkfb2, a key activator of glycolysis. Finally, we confirmed the role of glycolysis in modulating insulin action in insulin resistance. Our results underscore the significance of genetics in shaping global signalling responses and their adaptability to environmental changes, emphasising the utility of studying biological diversity with phosphoproteomics to discover key regulatory mechanisms of complex traits.

The genetic and dietary landscape of the muscle insulin signalling network

Metabolic disease is caused by a combination of genetic and environmental factors, yet few studies have examined how these factors influence signal transduction, a key mediator of metabolism. Using mass spectrometry-based phosphoproteomics, we quantified 23,126 phosphosites in skeletal muscle of five genetically distinct mouse strains in two dietary environments, with and without acute in vivo insulin stimulation. Almost half of the insulin-regulated phosphoproteome was modified by genetic background on an ordinary diet, and high-fat high-sugar feeding affected insulin signalling in a strain-dependent manner. Our data revealed coregulated subnetworks within the insulin signalling pathway, expanding our understanding of the pathway’s organisation. Furthermore, associating diverse signalling responses with insulin-stimulated glucose uptake uncovered regulators of muscle insulin responsiveness, including the regulatory phosphosite S469 on Pfkfb2, a key activator of glycolysis. Finally, we confirmed the role of glycolysis in modulating insulin action in insulin resistance. Our results underscore the significance of genetics in shaping global signalling responses and their adaptability to environmental changes, emphasising the utility of studying biological diversity with phosphoproteomics to discover key regulatory mechanisms of complex traits.

Effect of resveratrol on insulin action in primary myotubes from lean individuals and individuals with severe obesity.

Resveratrol, a natural polyphenol compound contained in numerous plants, has been proposed as a treatment for obesity-related disease processes such as insulin resistance. However, in humans there are conflicting results concerning the efficacy of resveratrol in improving insulin action; the purpose of the present study was to determine whether obesity status (lean, severely obese) affects the response to resveratrol in human skeletal muscle. Primary skeletal muscle cells were derived from biopsies obtained from age-matched lean and insulin-resistant women with severe obesity and incubated with resveratrol (1 µM) for 24 h. Insulin-stimulated glucose oxidation and incorporation into glycogen, insulin signal transduction, and energy-sensitive protein targets [AMP-activated protein kinase (AMPK), Sirt1, and PGC1α] were analyzed. Insulin-stimulated glycogen synthesis, glucose oxidation, and AMPK phosphorylation increased with resveratrol incubation compared with the nonresveratrol conditions (main treatment effect for resveratrol). Resveratrol further increased IRS1, Akt, and TBC1D4 insulin-stimulated phosphorylation and SIRT1 content in myotubes from lean women, but not in women with severe obesity. Resveratrol improves insulin action in primary human skeletal myotubes derived from lean women and women with severe obesity. In women with obesity, these improvements may be associated with enhanced AMPK phosphorylation with resveratrol treatment.NEW & NOTEWORTHY A physiologically relevant dose of resveratrol increases insulin-stimulated glucose oxidation and glycogen synthesis in myotubes from individuals with severe obesity. Furthermore, resveratrol improved insulin signal transduction in myotubes from lean individuals but not from individuals with obesity. Activation of AMPK plays a role in resveratrol-induced improvements in glucose metabolism in individuals with severe obesity.

Mechanistic Insight of Innovative Biomarkers for Screening of Type II Diabetes Mellitus

Abstract: Diabetes Mellitus (DM) is a compounded, persistent illness symbolized by an increased range of glucose levels in the blood caused by cellular resistance to insulin action, insufficient insulin production by pancreatic -cells, or both. Type 1 Diabetes Mellitus (T1DM), the extremely widespread form of DM, is recorded for almost 85-90% of worldwide cases. T2DM is mostly common in middle-aged and older people, and its causes are multifaceted. The use of efficient and profitable solutions for DM screening is critical to ensure pre-identification and minimising patients' risk of acquiring the life-compromising illness. Identification of innovative biomarkers with test methods of DM is therefore critical in order to establish vigorous, non-invasive, pain-free, highly sensitive, and precise procedures for screening. The purpose of this review article is to mention and review all the necessary biomarkers that play a vital role in disease diagnosis and to highlight the present-day findings of the latest clinically validated and traditional biomarkers and procedures for determining them, which provide cost-efficient options for T2DM screening with early detection. It is concluded that various biomarkers, both conventional and innovative, go hand in hand to diagnose the DM of any type.

The interplay between obesity, immunosenescence, and insulin resistance.

Obesity, which is the accumulation of fat in adipose tissue, has adverse impacts on human health. Obesity-related metabolic dysregulation has similarities to the metabolic alterations observed in aging. It has been shown that the adipocytes of obese individuals undergo cellular aging, known as senescence. Senescence can be transmitted to other normal cells through a series of chemical factors referred to as the senescence-associated secretory phenotype (SASP). Most of these factors are pro-inflammatory compounds. The immune system removes these senescent T-cells, but immunosenescence, which is the senescence of immune cells, disrupts the clearance of senescent T-cells. Immunosenescence occurs as a result of aging or indirectly through transmission from senescent tissues. The significant occurrence of senescence in obesity is expected to cause immunosenescence and impairs the immune response to resolve inflammation. The sustained and chronic inflammation disrupts insulin's metabolic actions in metabolic tissues. Therefore, this review focuses on the role of senescent adipocyte cells in obesity-associated immunosenescence and subsequent metabolic dysregulation. Moreover, the article suggests novel therapeutic approaches to improve metabolic syndrome by targeting senescent T-cells or using senotherapeutics.

The Role of Obesity in Type 2 Diabetes Mellitus-An Overview.

Obesity or excessive weight gain is identified as the most important and significant risk factor in the development and progression of type 2 diabetes mellitus (DM) in all age groups. It has reached pandemic dimensions, making the treatment of obesity crucial in the prevention and management of type 2 DM worldwide. Multiple clinical studies have demonstrated that moderate and sustained weight loss can improve blood glucose levels, insulin action and reduce the need for diabetic medications. A combined approach of diet, exercise and lifestyle modifications can successfully reduce obesity and subsequently ameliorate the ill effects and deadly complications of DM. This approach also helps largely in the prevention, control and remission of DM. Obesity and DM are chronic diseases that are increasing globally, requiring new approaches to manage and prevent diabetes in obese individuals. Therefore, it is essential to understand the mechanistic link between the two and design a comprehensive approach to increase life expectancy and improve the quality of life in patients with type 2 DM and obesity. This literature review provides explicit information on the clinical definitions of obesity and type 2 DM, the incidence and prevalence of type 2 DM in obese individuals, the indispensable role of obesity in the pathophysiology of type 2 DM and their mechanistic link. It also discusses clinical studies and outlines the recent management approaches for the treatment of these associated conditions. Additionally, in vivo studies on obesity and type 2 DM are discussed here as they pave the way for more rigorous development of therapeutic approaches.

Antidiabetic Effectiveness Test of Ethanol Extract of Brown Leaves (Theobroma Cacao L.) Against Mice (Mus Musculus)

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia that occurs due to abnormalities in insulin secretion, insulin action or both. DM sufferers are increasing from year to year, accompanied by increasing costs of therapy, therefore, as an alternative to controlling blood glucose levels, use natural ingredients such as cocoa leaves. The aim of this research was to determine the effectiveness of ethanol extract of cocoa leaves (Theobroma cacao L.) in reducing blood glucose levels in mice that had been induced by Aloxan. The research method used was experimental research. The research stages were sample collection, sample identification, making simpilicia, examining the characteristics of simpilicia, making extracts using maceration using 96% ethanol solvent, and testing the antidiabetic effect of EEDC in mice induced by alloxan at a dose of 175 mg/kg. bb intraperitoneally. Diabetic mice were divided into 5 groups, each group consisting of 5 mice that were given the test material 50 mg/KgBB of ethanol extract of brown leaves; 100 mg/KgBB; and 200 mg/KgBB, Metformin 65 mg/KgBB, and CMC 0.5%. Next, blood glucose levels were measured on days 3, 6, 9, 12, and 15, the percentage reduction in blood glucose levels was calculated, then the data was analyzed using the One-Way ANOVA method and Duncan's test, to see real differences between treatments. The research results showed that simplicia, the ethanol extract of brown leaves contains flavonoids, alkaloids, tannins, steroids/triterpenoids, saponins and glycosides. Cocoa leaf ethanol extract has effectiveness in lowering glucose levels, at the 5th and 6th hours it shows good effectiveness at a dose of 200 mg/KgBW of (72.16 ± 0.1.51)% and (82.80 ± 0.73 )%, not significantly different from metfromin 65 mg/KgBB of (74.45 ± 1.51)% and (83.29 ± 1.01).

Hasil Kadar HbA1C Penderita Diabetes Melitus Tipe 2 Pada Kelompok Prolanis Di Puskesmas Juhar Tahun 2023

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia that occurs due to abnormalities in insulin secretion, insulin action or both. The International Diabetes Federation (IDF) estimates that the number of diabetes sufferers in Indonesia could reach 28.57 million in 2045. This number is 47% greater than the number of 19.47 million in 2021. This research was conducted on patients who had been diagnosed with type 2 DM who were members of the Prolanis group. Prolanis is a health service system that aims to improve the quality of life of participants with chronic diseases, one of which is Diabetes Mellitus type 2. HbA1c is a substance formed from the reaction between glucose and hemoglobin. HbA1c is one of the parameters for assessing glycemic control (patient compliance). The research entitled Analysis of HbA1c Levels in Type 2 Diabetes Mellitus Sufferers in the Prolanis Group at the Juhar Community Health Center aims to analyze and measure HbA1c levels in Type 2 Diabetes Sufferers. The research method used was Descriptive Cross-sectional. The examination material used is median cubital vein blood with EDTA anticoagulant. From the results of the examination, 25 samples were obtained, of which 12 patients had HbA1c levels &gt;8% with criteria for poor DM control, 6 patients had HbA1c levels of 6.5-8% with criteria for moderate DM control, and there were 7 patients with HbA1c levels &lt;6.5%. with the criteria for good DM control. From the results of this study, it was found that controlling DM at the Juhar Community Health Center there were 14 patients who had HbA1c values above 6.5 and after follow-up for the next 6 months, some had HbA1c levels that decreased and others that increased. To obtain good DM control, it is best for people with diabetes to have an HbA1c check every 3 months as part of diabetes management and this management is very important to carry out in health services, including primary level health services.

Alterations in nonesterified free fatty acid trafficking rather than hyperandrogenism contribute to metabolic health in obese women with polycystic ovary syndrome

To determine whether alterations in nonesterified fatty acid (NEFA) dynamics or degree of hyperandrogenism (HA) contribute to the difference in insulin sensitivity between women with metabolically healthy obese polycystic ovary syndrome (PCOS) (MHO-PCOS) and women with metabolically unhealthy obese PCOS (MUO-PCOS). Prospective cross-sectional study. Tertiary-care academic center. One hundred twenty-five obese women with PCOS. Consecutive obese (body mass index [BMI] ≥ 30 kg/m2) oligo-ovulatory women (n = 125) with PCOS underwent an oral glucose tolerance test and a subgroup of 16 participants underwent a modified frequently sampled intravenous glucose tolerance test to determine insulin-glucose and -NEFA dynamics. Degree of insulin resistance (IR) in adipose tissue (AT) basally (Adipo-IR) and dynamically (the nadir in NEFA levels observed [NEFAnadir], the time it took for NEFA levels to reach nadir [TIMEnadir], and the percent suppression in plasma NEFA levels from baseline to nadir [%NEFAsupp]); peak lipolysis rate (SNEFA) and peak rate of NEFA disposal from plasma pool (KNEFA); whole-body insulin-glucose interaction (acute response of insulin to glucose [AIRg], insulin sensitivity index [Si], glucose effectiveness [Sg], and disposition index [Di]); and HA (hirsutism score, total and free testosterone levels, and dehydroepiandrosterone sulfate levels). A total of 85 (68%) women were MUO-PCOS and 40 (32%) were MHO-PCOS using the homeostasis model of assessment of IR. Subjects with MUO-PCOS and MHO-PCOS did not differ in mean age, BMI, waist-to-hip ratio, HA, and lipoprotein levels. By a modified frequently sampled intravenous glucose tolerance test, eight women with MUO-PCOS had lesser Si, KNEFA, and the percent suppression in plasma NEFA levels from baseline to nadir (%NEFAsupp) and greater TIMEnadir, NEFAnadir, and baseline adipose tissue IR index (Adipo-IR) than eight subjects with MHO-PCOS, but similar fasting NEFA levels and SNEFA. Women with MUO-PCOS had a higher homeostasis model of assessment-β% and fasting insulin levels than women with MHO-PCOS. In bivalent analysis, Si correlated strongly and negatively with Adipo-IR and NEFAnadir, weakly and negatively with TIMEnadir, and positively with KNEFA and %NEFAsupp, in women with MUO-PCOS only. Independent of age and BMI, women with MUO-PCOS have reduced NEFA uptake and altered insulin-mediated NEFA suppression, but no difference in HA, compared with women with MHO-PCOS. Altered insulin-mediated NEFA suppression, rather than HA or lipolysis rate, contributes to variations in insulin sensitivity among obese women with PCOS.

Therapeutic Potential of Fingolimod in Diabetes Mellitus and Its Chronic Complications.

Diabetes mellitus is a metabolic disease characterized by elevated blood glucose due to a deficiency of insulin secretion and/or action. Long-term poor blood glucose control may lead to chronic damage and dysfunction of the heart, kidneys, eyes, and other organs. Therefore, it is important to develop treatments for diabetes and its chronic complications. Fingolimod is a structural sphingosine analogue and sphingosine-1-phosphate receptor modulator currently used for the treatment of relapsing-remitting multiple sclerosis. Several studies have shown that it has beneficial effects on the improvement of diabetes and its chronic complications. This paper reviews the therapeutic potential of Fingolimod in diabetes and its chronic complications, aiming to further guide future treatment strategies.

Description of knowledge, attitudes and practices to maintain oral hygiene as well as gingival index and plaque index in children suffering from type 1 diabetes mellitus

Background: Diabetes mellitus is a chronic disease whose incidence continues to increase throughout the world. Periodontal disease is a complication of diabetes. Poor periodontal health can lead to a variety of serious health problems. Therefore, this research is considered important to determine knowledge, attitudes and practices to maintain oral hygiene as well as gingival index and plaque index in children with type 1 diabetes mellitus. Objectives: To determine the description of knowledge, attitudes and practices to maintain oral hygiene as well as gingival index and plaque index in children with type 1 diabetes mellitus. Method: This research is a cross-sectional observational analytical study consisting of 32 respondents from children suffering from T1DM and members of IKADAR Malang. The instrument used was a questionnaire to measure knowledge, attitudes and practices regarding cleaning teeth and mouth; insulin injection compliance, diet, and physical activity. Hba1c to determine DMT-1 status. Gingival and plaque index. Results and discussions: Respondents with controlled diabetes, good knowledge, attitudes and practices all had healthy gingiva and good PI, namely 3 (15.79%). respondents with regular insulin, good diet and low physical activity all had uncontrolled diabetes, namely 2 (7.14%). Conclusion: The majority of respondents have uncontrolled diabetes, knowledge, attitudes, practices to maintain good oral hygiene, healthy gingiva, and good PI in one unit, namely 9. The majority of respondents have regular insulin injection compliance, moderate diet, low physical activity, and uncontrolled diabetes mellitus status in one unit, namely 17.

EDUKASI DAN SKRINING DIABETES MELITUS PADA REMAJA DI RONGTENGAH SAMPANG MADURA

Diabetes mellitus is a heterogeneous group of disorders characterized by hyperglycemia resulting from absolute or relative deficits in insulin production or action. The increase in non-communicable diseases, one of which is diabetes mellitus. Diabetes mellitus in adolescents occurs at age ≥ 15 years. So to reduce the risk of early non-communicable diseases in adolescents, pro-health behavior is needed from adolescence through early detection. The aim of this activity is to increase understanding among teenagers about the dangers of diabetes mellitus so that they can adopt a healthy lifestyle and recognize early detection methods that can be used to prevent the disease. The method used in this community service activity is a presentation and discussion about the dangers of diabetes mellitus. To measure the level of participants' understanding regarding the dangers of diabetes mellitus, a pretest and posttest were carried out at the end of the activity. This activity was attended by 35 participants, namely teenagers aged 17-20 years in Rongtengah Sampang Madura. The average pretest score was 53.7 points, while the average posttest score was 72.3 points. These results indicate that there has been an increase in public knowledge about the meaning, risk factors, symptoms and ways to prevent diabetes mellitus. It is hoped that educational activities can be sustainable so that teenagers can apply ways to prevent diabetes mellitus